These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26047574)

  • 1. Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
    Adam O; Zimmer C; Hanke N; Hartmann RW; Klemmer B; Böhm M; Laufs U
    J Mol Cell Cardiol; 2015 Aug; 85():140-50. PubMed ID: 26047574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation.
    Adam O; Theobald K; Lavall D; Grube M; Kroemer HK; Ameling S; Schäfers HJ; Böhm M; Laufs U
    J Mol Cell Cardiol; 2011 Apr; 50(4):678-85. PubMed ID: 21215756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling.
    Lavall D; Jacobs N; Mahfoud F; Kolkhof P; Böhm M; Laufs U
    Biochem Pharmacol; 2019 Oct; 168():173-183. PubMed ID: 31283930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.
    Lavall D; Selzer C; Schuster P; Lenski M; Adam O; Schäfers HJ; Böhm M; Laufs U
    J Biol Chem; 2014 Mar; 289(10):6656-6668. PubMed ID: 24469458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling.
    Lavall D; Schuster P; Jacobs N; Kazakov A; Böhm M; Laufs U
    J Biol Chem; 2017 May; 292(18):7542-7553. PubMed ID: 28320863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation.
    Adam O; Lavall D; Theobald K; Hohl M; Grube M; Ameling S; Sussman MA; Rosenkranz S; Kroemer HK; Schäfers HJ; Böhm M; Laufs U
    J Am Coll Cardiol; 2010 Feb; 55(5):469-80. PubMed ID: 20117462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of torasemide and furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Thandavarayan RA; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Feb; 75(3):649-59. PubMed ID: 18001696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of various diuretics on cardiac function in rats with heart failure].
    Tanaka H; Watanabe K; Harima M; Thanikachalam PV; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
    Yakugaku Zasshi; 2009 Jul; 129(7):871-9. PubMed ID: 19571523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of miR-21 in the pathogenesis of atrial fibrosis.
    Adam O; Löhfelm B; Thum T; Gupta SK; Puhl SL; Schäfers HJ; Böhm M; Laufs U
    Basic Res Cardiol; 2012 Sep; 107(5):278. PubMed ID: 22760500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure.
    López B; Querejeta R; González A; Beaumont J; Larman M; Díez J
    Hypertension; 2009 Feb; 53(2):236-42. PubMed ID: 19075089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR‑132 in atrial fibrillation directly targets connective tissue growth factor.
    Qiao G; Xia D; Cheng Z; Zhang G
    Mol Med Rep; 2017 Oct; 16(4):4143-4150. PubMed ID: 28731126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H
    Su H; Su H; Liu CH; Hu HJ; Zhao JB; Zou T; Tang YX
    Cytokine; 2021 Oct; 146():155557. PubMed ID: 34303273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Eur J Pharmacol; 2008 Feb; 581(1-2):121-31. PubMed ID: 18154949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
    TORAFIC Investigators Group
    Clin Ther; 2011 Sep; 33(9):1204-1213.e3. PubMed ID: 21906812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy.
    Arumugam S; Sreedhar R; Miyashita S; Karuppagounder V; Thandavarayan RA; Giridharan VV; Pitchaimani V; Afrin R; Harima M; Suzuki K; Watanabe K
    Exp Mol Pathol; 2014 Aug; 97(1):137-43. PubMed ID: 24960275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-aldosteronergic effect of torasemide.
    Uchida T; Yamanaga K; Nishikawa M; Ohtaki Y; Kido H; Watanabe M
    Eur J Pharmacol; 1991 Nov; 205(2):145-50. PubMed ID: 1812004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFβ1 and HGF regulate CTGF expression in human atrial fibroblasts and are involved in atrial remodelling in patients with rheumatic heart disease.
    Chen JQ; Guo YS; Chen Q; Cheng XL; Xiang GJ; Chen MY; Wu HL; Huang QL; Zhu PL; Zhang JC
    J Cell Mol Med; 2019 Apr; 23(4):3032-3039. PubMed ID: 30697920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling.
    Reil JC; Hohl M; Oberhofer M; Kazakov A; Kaestner L; Mueller P; Adam O; Maack C; Lipp P; Mewis C; Allessie M; Laufs U; Böhm M; Neuberger HR
    Cardiovasc Res; 2010 Aug; 87(3):485-93. PubMed ID: 20211865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
    Díez J; Coca A; de Teresa E; Anguita M; Castro-Beiras A; Conthe P; Cobo E; Fernández E;
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):897-904. PubMed ID: 19673667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretic and vasodilating actions of torasemide.
    Uchida T; Yamanaga K; Kido H; Ohtaki Y; Watanabe M
    Cardiology; 1994; 84 Suppl 2():14-7. PubMed ID: 7954537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.